Article Details

Roche eyes April FDA verdict on Polivy as first-line lymphoma therapy - - Pharmaphorum

Retrieved on: 2022-08-16 16:20:59

Tags for this article:

Click the tags to see associated articles and topics

Roche eyes April FDA verdict on Polivy as first-line lymphoma therapy - - Pharmaphorum. View article details on HISWAI: https://pharmaphorum.com/news/roche-eyes-april-fda-verdict-on-polivy-as-first-line-lymphoma-therapy/

Excerpt

FDA is scheduled to deliver a verdict on Roche's Polivy in previously untreated diffuse large B-cell lymphoma by 2 April; pharma company says it ...

Article found on: pharmaphorum.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up